...
首页> 外文期刊>Journal of Surgical Oncology >Postmetastasis survival in high‐grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients
【24h】

Postmetastasis survival in high‐grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients

机译:高档末端骨肉瘤的治疗生存:126例患者预后因子的回顾性分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Objectives Prognostic factors predictive of postmetastasis survival (PMS) in metastatic osteosarcoma are poorly understood. Our aims were to evaluate PMS in patients with high‐grade osteosarcoma in extremities, and to identify prognostic factors related to PMS. Methods A retrospective review of data for 126 patients with metastatic osteosarcoma was conducted. The study population consisted of 70 men and 56 women, with a mean age of 21 years (range: 4‐75 years). The mean postmetastasis follow‐up period was 37 months (range: 1‐245 months). Results The 5‐year PMS rate was 31% and median PMS duration was 22 months. In the multivariate analyses, no metastasectomy ( P ??0.001), local recurrence prior to metastasis ( P ?=?0.016), extrapulmonary metastasis ( P ?=?0.006), and poor histologic response to preoperative chemotherapy ( P ?=?0.047) were significant poor prognostic factors. The 5‐year PMS without any negative prognostic factor was 60.2%; with one factor, 31.6%; and with more than two factors, 3.6%. Conclusions PMS in osteosarcoma patients was influenced by primary tumor‐related factors such as histologic response to chemotherapy, as well as metastasis‐related factors such as complete metastasectomy and metastasis site. A certain group of patients without such poor prognostic factors could be cured even after the development of metastasis.
机译:背景和目标预测因子预测转移性骨肉瘤中生存率(PMS)的预测性很差。我们的目标是评估患有高档骨肉瘤的患者患者,并鉴定与PM相关的预后因素。方法对126例转移性骨肉瘤患者进行回顾性审查。研究人口由70名男性和56名女性组成,平均年龄为21岁(范围:4-75岁)。平均后移动随访时间为37个月(范围:1-245个月)。结果5年的PM率为31%,中位数持续时间为22个月。在多变量分析中,在转移之前没有促乳切除术(p≤≤0.001),局部复发(p?= 0.016),外肺转移(p?= 0.006),对术前化疗的差的组织学反应(p?= 0.047)预后因素显着差。没有任何负面预后因子的5年的PMS为60.2%;一个因素,31.6%;并且有两个以上的因素,3.6%。结论骨肉瘤患者的PMS受到原发性肿瘤相关因素的影响,如组织学反应化疗,以及转移相关因素,如完全转移切除术和转移遗址。即使在转移发生后,某一组没有这种预后因子的患者也可以治愈。

著录项

  • 来源
    《Journal of Surgical Oncology》 |2018年第6期|共9页
  • 作者单位

    Department of Orthopaedic SurgeryUniversity of Ulsan College of MedicineSongpa‐gu Seoul Korea;

    Department of Orthopaedic SurgerySeoul National University HospitalSeoul Korea;

    Department of Orthopaedic SurgeryUniversity of Ulsan College of MedicineSongpa‐gu Seoul Korea;

    Department of Orthopaedic SurgerySeoul National University Bundang HospitalGyeonggi‐do Korea;

    Orthopaedic Oncology ClinicNational Cancer CenterIlsandong‐gu Goyang‐si Gyeonggi‐do Korea;

    Department of Orthopaedic SurgerySeoul National University HospitalSeoul Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    metastasis; osteosarcoma; prognostic factors; survival;

    机译:转移;骨肉瘤;预后因素;生存;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号